Cite
HARVARD Citation
Hehlmann, R. et al. (n.d.). Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY. American journal of hematology. 94 (1), pp. 46-54. [Online].